ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 190 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.75 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $1,077,000 | +306.4% | 44,485 | +797.1% | 0.00% | +100.0% |
Q4 2020 | $265,000 | -65.9% | 4,959 | -82.9% | 0.00% | -80.0% |
Q1 2019 | $776,000 | +288.0% | 29,043 | +199.8% | 0.01% | +400.0% |
Q3 2018 | $200,000 | -42.7% | 9,687 | -38.3% | 0.00% | -66.7% |
Q1 2018 | $349,000 | -23.6% | 15,695 | -0.8% | 0.00% | -25.0% |
Q4 2017 | $457,000 | +0.2% | 15,815 | +31.2% | 0.00% | 0.0% |
Q3 2017 | $456,000 | +38.2% | 12,058 | +2.0% | 0.00% | +33.3% |
Q2 2017 | $330,000 | -8.6% | 11,821 | +5.8% | 0.00% | 0.0% |
Q1 2017 | $361,000 | +35.7% | 11,171 | +8.5% | 0.00% | 0.0% |
Q4 2016 | $266,000 | +8.6% | 10,296 | +33.8% | 0.00% | 0.0% |
Q3 2016 | $245,000 | +17.8% | 7,697 | +18.5% | 0.00% | 0.0% |
Q2 2016 | $208,000 | -43.6% | 6,497 | -2.4% | 0.00% | +200.0% |
Q1 2016 | $369,000 | +81.8% | 6,660 | +6.8% | 0.00% | -66.7% |
Q1 2015 | $203,000 | – | 6,236 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Fairmount Funds Management LLC | 647,833 | $26,723,000 | 11.32% |
GREAT POINT PARTNERS LLC | 1,921,563 | $79,264,000 | 7.13% |
Baker Brothers Advisors | 41,904,586 | $1,728,564,000 | 6.91% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 486,000 | $20,048,000 | 6.47% |
Palo Alto Investors LP | 1,832,300 | $75,582,000 | 4.15% |
Birchview Capital, LP | 204,000 | $8,416,000 | 2.81% |
SECTORAL ASSET MANAGEMENT INC | 556,514 | $22,956,000 | 1.97% |
Rock Springs Capital Management LP | 1,573,200 | $64,895,000 | 1.65% |
Riggs Asset Managment Co. Inc. | 17,470 | $2,025,000 | 0.85% |
PFM Health Sciences, LP | 421,087 | $17,370,000 | 0.80% |